Investeringsforeningen Nykredit Invest Balance
19.1.2026 10:32:41 CET | Globenewswire | Press release
Investeringsforeningen Nykredit Invest Balance suspender handel med alle afdelinger
Investeringsforeningen Nykredit Invest Balance suspender handel med alle afdelinger
Nykredit Portefølje Administration A/S har anmodet Nasdaq Copenhagen om suspension af alle afdelinger, som administreres af Nykredit Portefølje Administration A/S. Det skyldes, at det grundet tekniske udfordringer ikke er muligt at stille korrekt NAV.
Suspensionen vil blive ophævet, når det igen er muligt at stille korrekte priser.
Følgende afdelinger er omfattet af suspensionen:
| Fund Name | ISIN | Order Book Code |
| Ansvarlig Defensiv | DK0061671013 | NBIAD |
| Ansvarlig Moderat | DK0061671286 | NBIAM |
| Ansvarlig Offensiv | DK0061671369 | NBIAO |
| Defensiv KL | DK0016188733 | NBIDEKL |
| Moderat KL | DK0016188816 | NBIMOKL |
| Offensiv KL | DK0060441749 | NBIOFKL |
Eventuelle spørgsmål vedrørende denne meddelelse kan rettes til npa.pm@nykredit.dk eller CRH@nykredit.dk.
Med venlig hilsen
Nykredit Portefølje Administration A/S
Tage Fabrin-Brasted
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Sonoco Products Company25.8.2026 19:00:00 CEST | Press release
Sonoco to Increase Paperboard Prices in EMEA Region
Park Street A/S25.8.2026 18:47:21 CEST | Press release
Park Street A/S – Park Street Interim Report Half Year 2026
2026 China International Fair for Trade in Services (CIFTIS)25.8.2026 17:10:17 CEST | Press release
Overseas session of 2026 CIFTIS held in Kristiansund, Norway
Volta Finance Limited25.8.2026 16:46:13 CEST | Press release
Volta Finance Limited Net Asset Value(s) as at 31 July 2026
Zymeworks Inc.25.8.2026 16:23:13 CEST | Press release
U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom